Market Snapshot

High-signal KPIs designed for executive scanning.

Indicative snapshot. Request sample for full model outputs.

Market Size (latest)

—

— vs. prior year

CAGR

—

Forecast window: —

Forecast Period

2024–2031

Base years: 2019–2023

Coverage Depth

—

Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

The global companion diagnostics (CDx) market is witnessing a significant transformation as precision medicine reshapes modern healthcare. Valued at USD 6.1 billion in 2023, the market is projected to reach USD 17.8 billion by 2031, growing at a 14.4% CAGR ClearView Market Insights, 2024. Three primary forces are driving this growth surge:

Precision Oncology at the Forefront

FDA-approved CDx assays now support over 80% of targeted cancer therapies.
Integration of next-generation sequencing (NGS)-based CDx is enabling pan-cancer applications.
Liquid biopsy-based CDx platforms are gaining traction for real-time, non-invasive tumor profiling.

Pharma-Diagnostic Co-Development Models

Co-development of drugs and diagnostics is accelerating therapy timelines and improving trial efficiency.
Strategic alliances between pharma giants and diagnostics firms (e.g., Roche & Foundation Medicine) are becoming standard.
Regulatory bodies are mandating CDx development alongside high-risk therapeutics in oncology and rare diseases.

Rising Demand in Non-Oncology Applications

Expansion of CDx into autoimmune, cardiovascular, and infectious disease domains is diversifying growth.
Pharmacogenomic CDx for drug metabolism prediction is gaining clinical relevance.
Companion tests for Alzheimer’s and depression drugs are entering clinical development stages.

Product Innovation Deep Dive

Oncology-Focused Companion Diagnostics

NGS Panels for Solid Tumors

Comprehensive genomic profiling panels approved for NSCLC, melanoma, and CRC.
Pan-cancer biomarker detection for MSI, TMB, and NTRK fusions.

Liquid Biopsy Innovations

ctDNA-based CDx tests enabling real-time treatment decisions.
MRD (Minimal Residual Disease) monitoring becoming a companion strategy for hematologic malignancies.

Tumor Microenvironment Profiling

PD-L1 expression and immune gene signatures used to guide checkpoint inhibitor therapies.
Multiplex immunofluorescence platforms introduced to assess tumor-immune interaction.

Non-Oncology Expansion Areas

Cardiovascular CDx

Genomic tests identifying responders to anti-thrombotic agents (e.g., clopidogrel).
RNA-based tests predicting heart failure therapy efficacy.

Neurological Disorders

CDx for amyloid-targeting Alzheimer’s therapies undergoing regulatory review.
Development of polygenic risk score-based CDx for psychiatric medication response.

Infectious Disease Applications

CDx tools stratifying patient response to antiviral therapies (e.g., HCV, HIV).
Companion tests supporting vaccine development in RSV and influenza.

Industry-Specific Advancements

Pharma-CDx Integration

Adaptive Trial Designs:
- Biomarker-enriched studies reducing R&D costs by up to 35%.
- Real-time molecular profiling enabling dynamic patient stratification.
Labeling and Regulatory Alignment:
- Co-labeled drug-CDx products receiving simultaneous FDA and EMA approvals.
- Global harmonization of CDx standards across regulatory regions.

Clinical and Lab Advancements

Technology	2024 Benchmark	Commercialization	Key Innovation
Digital Pathology-CDx	Adopted by 60% of US labs	2025	AI-enhanced image analysis for biomarker quantification
At-Home CDx Kits	Pilot launches in EU	2026	Patient-collected saliva tests for pharmacogenomic guidance
AI-Powered CDx Engines	Early-phase trials	2027	ML-driven matching of patients to targeted therapies

Competitive Landscape

Market Leaders

Company	Specialization	2024 Initiative	Market Share
Roche Diagnostics	Oncology CDx	Expansion of FoundationOne CDx for new indications	22%
Thermo Fisher	NGS-Based CDx	Launch of Oncomine Dx Express Test	18%
Qiagen	PCR-Based CDx	FDA approval for therascreen EGFR assay expansion	14%

Emerging Disruptors

Guardant Health: Leading in liquid biopsy-based CDx platforms
Grail: Multi-cancer early detection CDx using methylation patterns
Strata Oncology: Precision oncology CDx integrated into EHR workflows

Future Outlook

2024–2026

Rise of multi-analyte CDx panels combining DNA, RNA, and proteomic data
Standardization of CDx integration into clinical decision support systems

2027–2029

Real-time CDx monitoring enabled via smart wearables and biosensors
Expansion of AI-trained CDx platforms in clinical oncology trials

2030+

Genome-wide predictive CDx become integral to universal health screening
CDx embedded in digital twins for hyper-personalized drug development and therapy selection

Unlock the executive summary.

Request the sample to review key questions answered.

See what’s included.

Request sample for scope, definitions and segmentation.

Key Players

Roche Diagnostics
Agilent Technologies
Thermo Fisher Scientific
Abbott Laboratories
Qiagen N.V.

Competitive Dashboard Preview

Shortlist strategic accounts and benchmark positioning.

Loading…

Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.

Refine View

Geography Segment Sub-segment

—

Request A Custom Cut

Opportunity Index

Directional signals for prioritization and scenario framing.

Interactive

Need a board-ready slide? .

Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Global Companion Diagnostics Market Report

1. Global Companion Diagnostics Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Companion Diagnostics Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Companion Diagnostics Market Research Report - Preface
1. 2.1 Global Companion Diagnostics Market Research Report – Detailed Scope and Definitions
  1. 2.1.1 By Type
  2. 2.1.2 By Application
  3. 2.1.3 By End-user
  4. 2.1.4 By Region
3. Global Companion Diagnostics Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Type, By Application, By End-user, By Country
3. 3.3. Opportunities – By Type, By Application, By End-user, By Country
4. 3.4. Trends – By Type, By Application, By End-user, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Companion Diagnostics Market Research Report – DROTs Impact Analysis
4. Global Companion Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Companion Diagnostics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Genetic Tests
  1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Protein Biomarker Tests
  1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Companion Drug Tests
  1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Companion Diagnostics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Oncology
  1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Neurology
  1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Infectious Diseases
  1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Cardiology
  1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Companion Diagnostics Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Hospitals
  1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Clinics
  1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Research Institutes.
  1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Companion Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
  1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Europe
  1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 8.3 Asia-Pacific
  1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 8.4 Latin America
  1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 8.5 Middle East & Africa
  1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 8.6 Global Companion Diagnostics Market - Opportunity Analysis Index, By Type, By Application, By End-user, and Region, 2024 - 2031
9. North America Global Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.1.1 Genetic Tests
  2. 9.1.2 Protein Biomarker Tests
  3. 9.1.3 Companion Drug Tests
  9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.2.1 Oncology
  2. 9.2.2 Neurology
  3. 9.2.3 Infectious Diseases
  4. 9.2.4 Cardiology
  9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.3.1 Hospitals
  2. 9.3.2 Clinics
  3. 9.3.3 Research Institutes.
  9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.4.1 United States
  2. 9.4.2 Canada
  9.5 North America Global Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
  9.6 Regional Trends Analysis
  9.7 North America Global Companion Diagnostics Market Research Report - Company Profiles
  1. 9.7.1 Company 1 (United States)
  2. 9.7.2 Company 2 (Canada)
  3. 9.7.3 Company 3 (Canada)
10. Europe Global Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.1.1 Genetic Tests
  2. 10.1.2 Protein Biomarker Tests
  3. 10.1.3 Companion Drug Tests
  10.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.2.1 Oncology
  2. 10.2.2 Neurology
  3. 10.2.3 Infectious Diseases
  4. 10.2.4 Cardiology
  10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.3.1 Hospitals
  2. 10.3.2 Clinics
  3. 10.3.3 Research Institutes.
  10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.4.1 Germany
  2. 10.4.2 United Kingdom
  3. 10.4.3 France
  4. 10.4.4 Spain
  5. 10.4.5 Italy
  6. 10.4.6 Russia
  7. 10.4.7 Netherlands
  8. 10.4.8 Poland
  9. 10.4.9 Rest of Europe
  10.5 Europe Global Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
  10.6 Regional Trends Analysis
  10.7 Europe Global Companion Diagnostics Market Research Report - Company Profiles
  1. 10.7.1 Company 1 (Germany)
  2. 10.7.2 Company 2 (United Kingdom)
  3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.1.1 Genetic Tests
  2. 11.1.2 Protein Biomarker Tests
  3. 11.1.3 Companion Drug Tests
  11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.2.1 Oncology
  2. 11.2.2 Neurology
  3. 11.2.3 Infectious Diseases
  4. 11.2.4 Cardiology
  11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.3.1 Hospitals
  2. 11.3.2 Clinics
  3. 11.3.3 Research Institutes.
  11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.4.1 China
  2. 11.4.2 Japan
  3. 11.4.3 India
  4. 11.4.4 South Korea
  5. 11.4.5 Australia & NZ
  6. 11.4.6 ASEAN
  7. 11.4.7 Rest of Asia-Pacific
  11.5 Asia-Pacific Global Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
  11.6 Regional Trends Analysis
  11.7 Asia-Pacific Global Companion Diagnostics Market Research Report - Company Profiles
  1. 11.7.1 Company 1 (China)
  2. 11.7.2 Company 2 (Japan)
  3. 11.7.3 Company 3 (Japan)
12. Latin America Global Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.1.1 Genetic Tests
  2. 12.1.2 Protein Biomarker Tests
  3. 12.1.3 Companion Drug Tests
  12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.2.1 Oncology
  2. 12.2.2 Neurology
  3. 12.2.3 Infectious Diseases
  4. 12.2.4 Cardiology
  12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.3.1 Hospitals
  2. 12.3.2 Clinics
  3. 12.3.3 Research Institutes.
  12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.4.1 Brazil
  2. 12.4.2 Mexico
  3. 12.4.3 Argentina
  4. 12.4.4 Peru
  5. 12.4.5 Colombia
  6. 12.4.6 Rest of Latin America
  12.5 Latin America Global Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
  12.6 Regional Trends Analysis
  12.7 Latin America Global Companion Diagnostics Market Research Report - Company Profiles
  1. 12.7.1 Company 1 (Brazil)
  2. 12.7.2 Company 2 (Mexico)
  3. 12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.1.1 Genetic Tests
  2. 13.1.2 Protein Biomarker Tests
  3. 13.1.3 Companion Drug Tests
  13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.2.1 Oncology
  2. 13.2.2 Neurology
  3. 13.2.3 Infectious Diseases
  4. 13.2.4 Cardiology
  13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.3.1 Hospitals
  2. 13.3.2 Clinics
  3. 13.3.3 Research Institutes.
  13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 13.4.1 Saudi Arabia
  2. 13.4.2 UAE
  3. 13.4.3 South Africa
  4. 13.4.4 Egypt
  5. 13.4.5 Israel
  6. 13.4.6 Rest of Middle East and Africa
  13.5 Middle East & Africa Global Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
  13.6 Regional Trends Analysis
  13.7 Middle East & Africa Global Companion Diagnostics Market Research Report - Company Profiles
  1. 13.7.1 Company 1 (Saudi Arabia)
  2. 13.7.2 Company 2 (UAE)
  3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
1. 14.1 Strategic Dashboard of Top Market Players
  14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
  1. 14.2.1 Roche Diagnostics
  2. 14.2.2 Agilent Technologies
  3. 14.2.3 Thermo Fisher Scientific
  4. 14.2.4 Abbott Laboratories
  5. 14.2.5 Qiagen N.V.
15. Data Collection Method and Research Approach
16. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.

Triangulated Sizing

Bottom-up, top-down, and peer benchmarks reconciled by analysts.

Primary + Secondary Research

Executive interviews combined with validated public and paid sources.

Scenario & Sensitivity

Base, bull and bear cases to stress-test strategic moves.

Book A Consultation

Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.

Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30116 Dec. 1, 2025

$3600.00 single user

View report →

Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI0112 Dec. 1, 2025

$3600.00 single user

View report →

Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30115 Dec. 1, 2025

$3600.00 single user

View report →

Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30114 Nov. 30, 2025

$3600.00 single user

View report →

Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30113 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI3011 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30112 Nov. 30, 2025

$3600.00 single user

View report →

Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2711 Nov. 27, 2025

$3600.00 single user

View report →

Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI27111 Nov. 27, 2025

$3600.00 single user

View report →

Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2611 Nov. 26, 2025

$3600.00 single user

View report →

Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI26081 Aug. 26, 2025

$3600.00 single user

View report →

Global Osteo-Odonto-Keratoprosthesis (OOKP) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI1008 Aug. 10, 2025

$3600.00 single user

View report →

Ready to move from data to decision?

Get the report, request a sample, or book a consultative briefing.

Buy Report Talk To An Analyst

Global Companion Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis 2024 - 2031

Market Snapshot

Insights

Key Players

Segmentation Explorer

Table Of Contents

Global Companion Diagnostics Market Report

Methodology & Credibility

Related Reports